Saudi Arabia Diabetes Market Report: 2017 - 2022



IMARC’s new report “Saudi Arabia Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the Saudi Arabia diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Saudi Arabia. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Saudi Arabia diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Saudi Arabia diabetes market in any form.


What we have achieved in this report:


Comprehensive situation analysis of the Saudi Arabia diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in Saudi Arabia
  • Historical, current and future prevalence of type-1 and type-2 diabetes in Saudi Arabia
  • Historical, current and future prevalence of diabetes in the urban and rural regions in Saudi Arabia
  • Historical, current and future prevalence of diabetes among males and females in Saudi Arabia
  • Historical, current and future prevalence of diabetes among various age groups in Saudi Arabia
  • Historical, current and future diagnosis rates for diabetes in Saudi Arabia
  • Historical, current and future drug treatment rates for diabetes in Saudi Arabia


Comprehensive situation analysis of the Saudi Arabia Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in Saudi Arabia
  • Performance of key classes
  • Performance of key players
  • Market outlook


Comprehensive situation analysis of the Saudi Arabia Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in Saudi Arabia
  • Performance of key classes
  • Performance of key players
  • Market outlook

1 Preface
2 Research Methodology
3 Executive Summary
4 Introduction

    4.1 Overview
    4.2 Key Industry Trends
5 Diabetes Disease Overview
    5.1 What is Diabetes?
    5.2 Diabetes Diagnosis and Treatment
        5.2.1 Diagnosis
        5.2.2 Treatment
    5.3 Diabetes Complications
6 Saudi Arabia Diabetes Epidemiology
    6.1 Diabetes Population and Prevalence Rates
    6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    6.3 Population and Prevalence Rates by Region
    6.4 Population and Prevalence Rates by Gender
    6.5 Population and Prevalence Rates by Age Group
7 Saudi Arabia Diabetes Market
    7.1 Market Overview 
    7.2 Market Performance
    7.3 Market Forecast
    7.4 SWOT Analysis
         7.4.1    Strengths
         7.4.2    Weaknesses
         7.4.3    Opportunities
         7.4.4    Threats
    7.5    Value Chain Analysis
    7.6    Porter’s Five Forces Analysis
         7.6.1    Overview
         7.6.2    Bargaining Power of Buyers
         7.6.3    Bargaining Power of Suppliers
         7.6.4    Degree of Competition
         7.6.5    Threat of New Entrants
         7.6.6    Threat of Substitutes
    7.7 Market Breakup by Segment
        7.7.1 Saudi Arabia Oral Antidiabetics Market
            7.7.1.1 Historical Market Trends
            7.7.1.2 Market Breakup by Class
            7.7.1.3 Market Shares of Key Players
            7.7.1.4 Market Forecast
        7.7.2 Saudi Arabia Insulin Market
            7.7.2.1 Historical Market Trends
            7.7.2.2 Market Breakup by Class
            7.7.2.3 Market Shares of Key Players
            7.7.2.4 Market Forecast
    7.8 Competitive Landscape
        7.8.1 Competitive Structure
        7.8.2 Profiles of Key Players

 

List of Figures
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2016 & 2035
Figure 4: Saudi Arabia: Overweight & Obese Population* (in Million), 2010, 2016 & 2022
Figure 5: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 6: Saudi Arabia: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
Figure 7: Saudi Arabia: Diabetes Prevalence By Age Groups, (in %)
Figure 8: Saudi Arabia: Total Number of Diabetes Patients* (in 000), 2009-2016
Figure 9: Saudi Arabia: Total Number of Diabetes Patients* Forecast (in 000), 2017-2022
Figure 10: Saudi Arabia (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2009- 2016
Figure 11: Saudi Arabia (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2017-2022
Figure 12: Saudi Arabia (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2009 -2022
Figure 13: Saudi Arabia (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2017 - 2022
Figure 14: Saudi Arabia (Male & Female): Total Number of Diabetes Patients* (in 000), 2009 - 2016
Figure 15: Saudi Arabia (Male & Female): Total Number of Diabetes Patients* (in 000), 2017 - 2022
Figure 16: Saudi Arabia: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2009 - 2016
Figure 17: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2017 – 2022
Figure 18: Saudi Arabia: Diabetes Drug Industry Overview
Figure 19: Saudi Arabia: Diabetes Drug Market (in Million US$), 2009 - 2016
Figure 20: Saudi Arabia: Diabetes Drug Market Forecast (in Million US$), 2017 – 2022
Figure 21: Saudi Arabia: Diabetes Drug Market: SWOT Analysis
Figure 22: Saudi Arabia: Diabetes Drug Market: Value Chain Analysis
Figure 23: Saudi Arabia: Diabetes Drug Market: Porters Five Forces Analysis
Figure 24: Saudi Arabia: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2009 - 2016
Figure 25: Saudi Arabia: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2017 - 2022
Figure 26: Saudi Arabia: Oral Antidiabetics Market: (in Million US$), 2009 - 2016
Figure 27: Saudi Arabia: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009 & 2016
Figure 28: Saudi Arabia: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 29: Saudi Arabia: Oral Antidiabetics Market: (in Million US$), 2017 - 2022
Figure 30: Saudi Arabia: Insulin Market, (in Million US$), 2009 - 2016
Figure 31: Saudi Arabia: Breakup of Insulin Market by Class (in %)
Figure 32: Saudi Arabia: Insulin Market: Sales Share of Key Players (in %)
Figure 33: Saudi Arabia: Insulin Market Forecast (in Million US$), 2017 - 2022

 

List of Tables
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2016 & 2035
Table 3: Saudi Arabia: Overweight & Obesity Statistics, 2010, 2016 & 2022
Table 4: Saudi Arabia: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
Table 5: Saudi Arabia: Total Prevalence & Number of Diabetes Patients*, 2009, 2016 & 2022
Table 6: Saudi Arabia (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 7: Saudi Arabia (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 8: Saudi Arabia (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 9: Saudi Arabia: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2022
Table 10: Saudi Arabia: Diabetes Drug Market: Competitive Structure


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Artificial organs are engineered devices that are implanted in a human body in order to replace a natural organ or perform a specific function. They are composed of the plastic that is seeded with stem cells from the transplant recipient, hence the body’s immune system does not reject the artifici...


Biopreservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

The latest report by IMARC Group, titled “Biopreservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the market has witnessed a healthy growth over the past few years, reaching a value of about US$ 2.5 Billion in 2016.


GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GCC generic drugs industry in any manner.


US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s new report titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the US generic injectables market reached a value of US$ 10 Billion in 2016, exhibiting a CAGR of more than 9% during 2009-2016.


Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s latest report titled, “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global generic injectables market reached a value of more than US$ 23 Billion in 2016, exhibiting a CAGR of around 9% during 2009-...